Results 131 to 140 of about 4,485 (207)

Closing Evidence Gaps on the Prevalence and Harms of New Psychoactive Substances in Scotland [PDF]

open access: yes, 2015
This paper considers the state of knowledge on New Psychoactive Substances (NPS) in Scotland, with a focus on prevalence and harms and puts forward proposals which may assist in closing existing evidence ...
Gillies, Allan
core  

New psychoactive substances in England: a review of the evidence. [PDF]

open access: yes, 2014
Aims and approach: This report builds on chapter 2 of the report of the expert panel review, and provides an overview of the current available evidence on New Psychoactive Substances (NPS)1. Conclusion: • NPS is a new and developing area of study.
Richardson, Anna, Stephenson, Giles
core  

3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. [PDF]

open access: yesFront Psychiatry, 2022
López-Arnau R   +8 more
europepmc   +1 more source

Emerging drugs of abuse: current perspectives on substituted cathinones

open access: yesSubstance Abuse and Rehabilitation, 2014
Magalie Paillet-Loilier,1 Alexandre Cesbron,1 Reynald Le Boisselier,2 Joanna Bourgine,1 Danièle Debruyne1,2 1Toxicology and Pharmacology Laboratory, 2Centre d'Evaluation et d'Information sur la Pharmacodépendance
Paillet-Loilier M   +4 more
doaj  

Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys. [PDF]

open access: yesInt J Neuropsychopharmacol, 2021
Wakeford AGP   +5 more
europepmc   +1 more source

4-Methylethcathinone (4-MEC). Critical Review Report. Agenda Item 4.3. [PDF]

open access: yes
Expert Committee on Drug Dependence. World Health Organisation. Thirty-eighth Meeting.
Brandt, SD
core  

New Synthetic Cathinones and Phenylethylamine Derivatives Analysis in Hair: A Review. [PDF]

open access: yesMolecules, 2021
Bolcato V   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy